文献速递衰弱、肌少症与跌倒老年慢病共病管理

镰状细胞病成人的衰弱表型研究

Frailty phenotype in adults with sickle cell disease.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2026-01-01

这项单中心横断面研究分析了137名成人镰状细胞病患者的衰弱表型,发现2%衰弱、47%衰弱前期、51%健壮。衰弱/衰弱前期者较健壮者更多有急诊就诊、高血压、糖尿病、更多镰状细胞病并发症及更差的社会经济状况、认知功能、抑郁、身体功能和日常生活活动能力障碍。

要点

  • 镰状细胞病成人中衰弱前期占47%,与普通老年人群相似,支持加速衰老。
  • 衰弱/衰弱前期者较健壮者更易有急诊就诊、高血压、糖尿病及更多并发症。
  • 需早期识别并干预以预防和减轻镰状细胞病患者的衰弱。

核心结论

  • 镰状细胞病成人中衰弱前期患病率与普通老年人群相似,支持该人群存在加速衰老,强调早期识别和干预的必要性。

研究设计与样本

  • 单中心横断面研究,纳入137名年龄≥18岁的镰状细胞病成人,平均年龄45岁(范围19-82岁)。

主要发现

  • 3名(2%)参与者为衰弱,47%为衰弱前期,51%为健壮。
  • 与健壮者相比,衰弱/衰弱前期者过去一年急诊就诊更多(66% vs 46%;p < .02)。
  • 衰弱/衰弱前期者高血压(42% vs 19%;p < .003)和糖尿病(16% vs 4%;p < .02)比例更高。
  • 衰弱/衰弱前期者镰状细胞病并发症更多(2.8 vs 2.1;p < .02),社会经济状况、认知功能、抑郁、身体功能和日常生活活动能力障碍更差。

关键数值与推荐

  • 衰弱定义为满足以下≥3项标准:行动迟缓、无力、体重下降、体力活动低、疲惫。
  • 满足1-2项标准为衰弱前期,无标准为健壮。

临床怎么用

  • 在镰状细胞病成人中应早期评估衰弱表型,识别衰弱前期并启动干预以预防或减轻衰弱。

局限性

  • 本研究为单中心横断面研究,样本量137例,可能限制普遍性。
  • 未来研究将评估镰状细胞病特异性的衰弱组分切点以预测临床有意义结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People with sickle cell disease (SCD) are at risk for accelerated biological aging and functional decline due to both age and SCD-related stressors. Frailty is characterized by decreased physiologic reserve and increased vulnerability to stressors that can lead to disability and death. The purpose of this study was to evaluate frailty phenotype in adults with SCD and identify factors associated with frailty. METHODS: Frailty was defined by meeting ≥3 of the following criteria: slowness, weakness, weight loss, low physical activity, and exhaustion. Participants meeting 1-2 criteria were prefrail and "robust" if no criteria were present. RESULTS: We analyzed frailty in 137 adults (age ≥ 18) with SCD in a single-center cross-sectional study (mean age 45; range 19-82). Three (2%) participants were frail, 47% prefrail, and 51% robust. Compared to robust, frail/prefrail participants were more likely to have emergency department visits in the past year (66% vs 46%; p < .02), hypertension (42% vs 19%; p < .003), diabetes (16% vs 4%; p < .02), more SCD complications (2.8 vs 2.1; p < .02), and significantly worse socioeconomic status, cognitive function, depression, physical function, and disability in activities of daily living. CONCLUSIONS: The prevalence of prefrailty in this sample of young and predominantly middle-aged adults with SCD was similar to older adults in the general population, further supporting that accelerated aging occurs in this population and emphasizing the need for early identification and initiation of interventions to prevent and attenuate frailty in SCD. In future studies, we will evaluate SCD-specific cutpoints for frailty components that predict clinically meaningful outcomes.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Oyedeji CI, Mohamed RE, Faldowski R, et al. Frailty phenotype in adults with sickle cell disease. J Gerontol A Biol Sci Med Sci. 2026. PMID: 41926751. doi:10.1093/gerona/glag091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。